Delivery Order SPE2DB24D8001-SPE2DB25FKZDR

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $8.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical's ECAT Generation V Program. The $11,143.01 firm fixed-price delivery order contract has an ultimate completion date of January 24, 2025. It is an unrestricted, non-set-aside contract for the delivery of the prescription medication Latuda 20 mg tablets. Dakota Drug, Inc. also holds a $999,999,999.00 Indefinite...
This federal contract award, with the ID SPE2DB24D8003|SPE2DB25FJTNZ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of LATUDA 80 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,106.75 and a completion date of January 2, 2025. This contract is not set aside and is a firm fixed-price delivery order. Dakota Drug, Inc. is a key supplier for the DLA Troop...
This federal contract award, identified as SPE2DB24D8002|SPE2DB25FJNHW, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the pharmaceutical product LATUDA 60 MG TABLET 30S. The contract has a firm fixed price ceiling value of $11,462.09 and an ultimate completion date of March 18, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, holding a significant single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,575.82 firm fixed-price delivery order contract is for the supply of Latuda 80 mg tablets to support federal healthcare programs. The contract is not designated with a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $23,964.25 contract is for the supply of Latuda 80 mg tablets to support federal healthcare programs. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Latuda 20 mg tablets to support federal healthcare programs. The $6,673.60 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies and equipment to the U.S. military and other federal entities. The contract has a total period of performance through July 2, 2024. This award is part of a larger...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,756.22 firm fixed-price contract is for the delivery of Lialda DR 1.2 GM Tablet, a prescription medication, with a period of performance ending on November 28, 2023. Dakota Drug, Inc. is an experienced federal contractor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,914.79, is for the delivery of Latuda 60 mg tablets, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of January 13, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,859.22 firm fixed-price delivery order is for the supply of LATUDA 40 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAJX8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,467.22 firm fixed-price delivery order is for the supply of Latuda 80 mg tablets, a mental health treatment medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB25FKZDR
    Delivery Order

This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical's ECAT Generation V Program. The $8,713.40 firm fixed-price delivery order is for the supply of Latuda 80 mg tablets, a prescription medication, with a period of performance through February 6, 2025.

Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This delivery order is one of many awarded to Dakota Drug, Inc. under the IDC contract, positioning the company as a key strategic supplier for the DLA's medical supply chain needs. The contract does not have a set-aside designation.

Generated 5/21/25, 9:52 AM